These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9613080)

  • 21. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated NCEP guidelines set new decision points for managing dyslipidemia.
    Stevenson MM
    Geriatrics; 2001 Jul; 56(7):50-2, 61. PubMed ID: 11490987
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
    Kovács I; Tarján J; Császár A
    Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-carbohydrate diet and blood lipid levels: how good and how fast?
    Giugliano D; Maiorino MI; Esposito K
    Arch Intern Med; 2009 Nov; 169(20):1930; author reply 1930-1. PubMed ID: 19901151
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of hyperlipidemia.
    Low Dog T; Riley D
    Altern Ther Health Med; 2003; 9(3):28-40; quiz 41. PubMed ID: 12776473
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimization of magnesium therapy after severe diffuse axonal brain injury in rats.
    Heath DL; Vink R
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1311-6. PubMed ID: 10027872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipostabil forte in the control of hyperlipidemia in diabetics].
    Tomasević M; Zulić S
    Med Arh; 1984; 38(6):279-82. PubMed ID: 6400977
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum lipid profile and timolol gel.
    Khamar MB; Bhatt N; Patel K
    J Indian Med Assoc; 2002 Oct; 100(10):620-1. PubMed ID: 12452518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of mangesium salts and their combinations with vitamin B6 on oxalates crystalluria in rats fed with pyridoxine-deficient diet].
    Spasov AA; Iezhitsa IN; Kharitonova MV; Kravchenko MS
    Urologiia; 2009; (3):22-5. PubMed ID: 19670811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study.
    Rubenfire M;
    Am J Cardiol; 2004 Aug; 94(3):306-11. PubMed ID: 15276093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of essential phospholipids in the control and prevention of hyperlipemia in young and middle-aged persons].
    Stanković D; Zulić I; Grujić-Vasić J; Nikolin B; Stanković J
    Med Arh; 1974; 28(3):287-96. PubMed ID: 4469566
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].
    Ferrières J; Elbaz M; Maupas E; Carriè D; Puel J
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):187-93. PubMed ID: 15106741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Milestone in the treatment of diabetic dyslipidemia: the DAIS Study].
    Forster T
    Orv Hetil; 2001 Jul; 142(29):1588-9. PubMed ID: 11494751
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipokines and treatment with niacin.
    Westphal S; Borucki K; Taneva E; Makarova R; Luley C
    Metabolism; 2006 Oct; 55(10):1283-5. PubMed ID: 16979396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
    Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Piperazine sultosylate in the treatment of hyperlipidemias].
    Balaguer Vintro I; Duarte Mantilla G
    Rev Clin Esp; 1980 Jul 15-31; 158(1-2):37-40. PubMed ID: 6999559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.